Air Pollution's Toll Across the BRICS Nations, 1990 to 2023

Tiny particles small enough to slip deep into the lungs remain one of the largest environmental threats to human health. A new analysis traces how that threat has shifted across five of the world's most populous nations over thirty-three years.

Fine particulate matter, the mixture of microscopic solids and liquid droplets known as PM2.5, is small enough to travel deep into the lungs and enter the bloodstream. It comes from traffic, industry, coal burning, cooking fires and dust, and it has been linked in a large body of research to heart disease, stroke, lung disease, respiratory infections and some cancers. Researchers set out to describe how the health toll of this pollution has changed across the five BRICS nations, a group that together holds a large share of the world's population and includes both rapidly industrialising and heavily polluted regions: Brazil, Russia, India, China and South Africa. To do this they drew on the Global Burden of Disease Study 2023, an ongoing international project that estimates illness and death from hundreds of causes by combining surveys, registries, pollution measurements and statistical modelling. The team tracked the burden attributed to PM2.5 from 1990 through 2023, looking both at the raw number of deaths and years of healthy life lost and at rates adjusted for the size and age structure of each population.

The picture that emerges is one of large and persistent, though shifting, harm. Across the BRICS group, fine particulate pollution remained a major contributor to death and disability throughout the study period. When rates are adjusted for age, several countries show meaningful declines over the decades, a sign that cleaner air policies, changing fuel use and improved healthcare have made progress in relative terms. Yet the absolute counts tell a harder story. Because populations grew and aged, the sheer number of people affected did not fall as quickly, and in some settings stayed stubbornly high. The heaviest contributions came through cardiovascular and respiratory disease, the conditions most consistently tied to long-term particle exposure. The burden was not shared equally between the five nations or across age groups, with older adults carrying a disproportionate share. These are modelled estimates rather than a direct headcount, so the exact figures carry uncertainty, but the direction and scale are consistent with decades of environmental health research.

None of this overturns the established understanding that dirty air damages health. What the analysis adds is a careful, comparative accounting across a specific and important set of countries over a long span of time. It shows that progress measured one way, as age-standardised rates, can coexist with stagnation measured another way, as the total number of people harmed. That distinction matters for anyone trying to judge whether a country is winning or losing against air pollution. A falling rate can look like success while the human cost, counted in lives, holds steady or climbs because there are simply more people, and more older people, exposed. The work also underscores how much of the global air pollution burden is concentrated in a handful of large, populous nations, which is where policy choices about energy, transport and industry carry the greatest weight.

The study describes associations at the level of whole populations. It cannot say what any individual's exposure did to their health, and it does not prove that a specific level of pollution caused a specific death. Burden estimates of this kind rest on assumptions about how exposure translates into risk, drawn from other studies, and on pollution data that is sparser in some regions than others. Where monitoring is thin, the numbers depend more heavily on modelling. Comparisons between countries can also be affected by differences in how deaths and diseases are recorded. The result is best read as a well-founded description of scale and trend, not as a precise measurement.

For the general reader, the value of an analysis like this is less about personal action and more about seeing where the largest opportunities for public health lie. Air quality is shaped mostly by policy and infrastructure rather than individual behaviour, which is why the persistent burden documented here points toward decisions made by governments and industry: how electricity is generated, how cities move people, how homes are heated and cooked in. On an individual level, people living in areas with poor air quality may find it worth being aware of local pollution forecasts and, where relevant, discussing respiratory or cardiovascular concerns with a clinician. But the central message of the study is structural. Cleaner air, achieved and sustained, would spare a very large number of people from illness and premature death.

This is a descriptive burden analysis built on aggregated, modelled data rather than a controlled study, so it establishes association and scale rather than direct causation. The underlying estimates carry uncertainty that grows where pollution monitoring and health records are less complete, and cross-country comparisons can be shaped by reporting differences. The findings should be understood as population-level patterns, not as evidence about what pollution does to any single person.

Across five of the world's most populous countries, fine particulate pollution has remained a heavy and unevenly shared burden for more than three decades. Relative rates have improved in places, but the number of people harmed has proven far harder to bring down. The finding is a reminder that the fight against dirty air is measured not only in cleaner statistics but in the millions of lives that cleaner statistics represent.